Scientific article
Infection control, genetic assessment of drug resistance and drug susceptibility testing in the current management of multidrug/extensively-resistant tuberculosis (M/XDR-TB) in Europe: A tuberculosis network European Trialsgroup (TBNET) study
ContributorsBothamley, Graham H; Lange, Christoph; TBnet study
CollaboratorsJanssens, Jean-Paul
Published inRespiratory Medicine, vol. 132, p. 68-75
Publication date2017
Abstract
Keywords
- Antitubercular Agents/therapeutic use
- Decontamination/methods
- Developing Countries
- Drug Resistance
- Bacterial/genetics
- Europe
- Extensively Drug-Resistant Tuberculosis/diagnosis/drug therapy
- Humans
- Infection Control/methods
- Microbial Sensitivity Tests
- Mycobacterium tuberculosis/genetics
- Patient Isolation/methods
- Rifampin/therapeutic use
- Surveys and Questionnaires
- Tuberculosis
- Multidrug-Resistant/diagnosis/drug therapy
- Ultraviolet Rays
- Tuberculosis
- Drug-resistance
- Europe
- PCR
- Infection control
Affiliation entities
Research groups
Citation (ISO format)
BOTHAMLEY, Graham H, LANGE, Christoph. Infection control, genetic assessment of drug resistance and drug susceptibility testing in the current management of multidrug/extensively-resistant tuberculosis (M/XDR-TB) in Europe: A tuberculosis network European Trialsgroup (TBNET) study. In: Respiratory Medicine, 2017, vol. 132, p. 68–75. doi: 10.1016/j.rmed.2017.09.007
Main files (1)
Article (Published version)
Secondary files (1)
Supplemental data
Identifiers
- PID : unige:127786
- DOI : 10.1016/j.rmed.2017.09.007
- PMID : 29229108
Additional URL for this publicationhttps://www.sciencedirect.com/science/article/pii/S0954611117303268
Journal ISSN0954-6111
